In the first six months of 2013, Biofarm posted a net profit of RON13.54 million.
The company said total sales increased 4.7% on the year to RON61.1 million in the first half, from RON58.37 million in the year-earlier period.
Operating profit was up 8% to RON15.4 million.
The company expects a full-year net profit of RON21.7 million in 2014, down 15% from the previous year.
Biofarm has a share capital of RON109.4 million split into 1.09 billion shares with a face value of RON0.1.
Romanian regional investment funds SIF Oltenia (SIF5.RO), SIF Banat Crisana (SIF1.RO) and SIF Moldova (SIF2.RO) own together around 87% of Biofarm’s shares.
On the Bucharest bourse Thursday, Biofarm closed down 1.23% at RON0.281 a share, valuing the company at some RON306 million. (EUR1=RON4.4372)